Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

ACTIVE SURVEILLANCE OF THE SPUTNIK V VACCINE IN HEALTH WORKERS

Vanina Pagotto, Analia Ferloni, María Mercedes Soriano, Morena Díaz, Manuel Braguisnky Golde, María Isabel González, Valeria Asprea, Inés Staneloni, Gustavo Vidal, Martin Silveira, Paula Zingoni, Valeria Aliperti, Hernan Michelangelo, View ORCID ProfileSilvana Figar
doi: https://doi.org/10.1101/2021.02.03.21251071
Vanina Pagotto
1Department of Research
2Area of Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Analia Ferloni
2Area of Epidemiology
4Area of health Quality
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Mercedes Soriano
2Area of Epidemiology
4Area of health Quality
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morena Díaz
1Department of Research
2Area of Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Braguisnky Golde
2Area of Epidemiology
4Area of health Quality
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Isabel González
3Department of Nursing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria Asprea
6Area of human resources
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inés Staneloni
5Infection Control Committee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gustavo Vidal
7Area of Pharmacy from Hospital Italiano de Buenos Aires
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Silveira
7Area of Pharmacy from Hospital Italiano de Buenos Aires
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Zingoni
8Area of Operational Planning of the Ministry of Health of Buenos Aires City
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria Aliperti
2Area of Epidemiology
4Area of health Quality
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hernan Michelangelo
4Area of health Quality
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvana Figar
1Department of Research
2Area of Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Silvana Figar
  • For correspondence: silvana.figar@hospitalitaliano.org.ar
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction The World Health Organization (WHO) recommends vaccination against Sars Cov-2 coronavirus to mitigate COVID-19 pandemic. On December 29th, the Argentine Ministry of Health started a vaccination plan with the Sputnik V vaccine emphasizing the registration of the Events Supposedly Attributed to Vaccines and Immunizations (ESAVI) in the National Surveillance System. The aim of this study is to determine the safety of this vaccine.

Methods In an ongoing cohort study, health professionals from Hospital Italiano de Buenos Aires vaccinated with the first component of the Sputnik V vaccine (a rAd26 vector-based) were followed up. Safety at 72 hs was analysed from a self-report form. Local and systemic reactions were characterized as mild, moderate and severe. Incident rates were calculated per 1000 person-hours by age groups and gender. Adjusted hazard ratio and 95% Confidence Interval (HR; 95%CI) is obtained by Cox Regression Model.

Results 707 health professionals (mean age 35, 67% female) were vaccinated, response rate was 96,6% and 71,3% reported at least one ESAVI. Rate was 6.3 per 1.000 person-hours. Among local reactions, 54% reported pain at the injection site, 11% redness and swelling. Among systemic reactions 40% reported fever, 5% diarrhea and 68% new or worsened muscle pain. Five percent had serious adverse events that required medical evaluation and one inpatient.

ESAVI rate was higher among females (65.4% vs 50%; HR 1.38, 95%CI 1.13-5.38) and in younger than 55 years-old (72.8% vs 32%; HR 2.66, 95%CI 1.32-1.68).

Conclusion Active surveillance on safety for vaccines with emergency approval is mandatory. This study shows high rates of local and systemic reactions however early serious events were rare. Short term safety is supported by these preliminary findings. Studies on long term safety and efficacy, accoding sex and age, are needed.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is a cohort design study

Funding Statement

This study was funded by the Hospital Italiano de Buenos Aires as an independent research from the Department of Research.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol was approved by the Research Protocol Ethics Committee of the Hospital Italiano de Buenos Aires under number 3876

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All raw data is available under request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 05, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
ACTIVE SURVEILLANCE OF THE SPUTNIK V VACCINE IN HEALTH WORKERS
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
ACTIVE SURVEILLANCE OF THE SPUTNIK V VACCINE IN HEALTH WORKERS
Vanina Pagotto, Analia Ferloni, María Mercedes Soriano, Morena Díaz, Manuel Braguisnky Golde, María Isabel González, Valeria Asprea, Inés Staneloni, Gustavo Vidal, Martin Silveira, Paula Zingoni, Valeria Aliperti, Hernan Michelangelo, Silvana Figar
medRxiv 2021.02.03.21251071; doi: https://doi.org/10.1101/2021.02.03.21251071
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
ACTIVE SURVEILLANCE OF THE SPUTNIK V VACCINE IN HEALTH WORKERS
Vanina Pagotto, Analia Ferloni, María Mercedes Soriano, Morena Díaz, Manuel Braguisnky Golde, María Isabel González, Valeria Asprea, Inés Staneloni, Gustavo Vidal, Martin Silveira, Paula Zingoni, Valeria Aliperti, Hernan Michelangelo, Silvana Figar
medRxiv 2021.02.03.21251071; doi: https://doi.org/10.1101/2021.02.03.21251071

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)